Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas

被引:101
|
作者
Le, Quynh-Thu
Kong, Christina
Lavori, Phfllip W.
O'Byrne, Ken
Erler, Janine T.
Huang, Xin
Chen, Yijun
Cao, Hongbin
Tibshiran, Robert
Denko, Nic
Giaccia, Amato J.
Koong, Albert C.
机构
[1] Stanford Univ, Med Ctr, Dept Radiat Oncol, Stanford, CA 94305 USA
[2] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA
[3] Stanford Univ, Med Ctr, Dept Hlth & Human Serv, Stanford, CA 94305 USA
[4] Univ Hosp Leicester NHS Trust, Dept Oncol, Leicester, Leics, England
[5] Univ Hosp Leicester NHS Trust, Dept Pathol, Leicester, Leics, England
[6] Univ Hosp Leicester NHS Trust, Dept Epidemiol, Leicester, Leics, England
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 69卷 / 01期
关键词
D O I
10.1016/j.ijrobp.2007.01.071
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate the expression pattern of hypoxia-induced proteins identified as being involved in malignant progression of head-and-neck squamous cell carcinoma (HNSCC) and to determine their relationship to tumor PO2 and prognosis. Methods and Materials: We performed immumohistochemical staining of hypoxia-induced proteins (carbonic anhydrase IX [CA IX], BNIP3L, connective tissue growth factor, osteopontin, ephrin At, hypoxia inducible gene-2, dihydrofolate reductase, galectin-1, I kappa B kinase beta, and lysyl oxidase) on tumor tissue arrays of 101 HNSCC patients with pretreatment PO2 measurements. Analysis of variance and Fisher's exact tests were used to evaluate the relationship between marker expression, tumor PO2, and CA IX staining. Cox proportional hazard model and log-rank tests were used to determine the relationship between markers and prognosis. Results: Osteopontin expression correlated with tumor PO2 (Eppendorf measurements) (p = 0.04). However, there was a strong correlation between lysyl oxidase, ephrin At, and galectin-1 and CA IX staining. These markers also predicted for cancer-specific survival and overall survival on univariate analysis. A hypoxia score of 0-5 was assigned to each patient, on the basis of the presence of strong staining for these markers, whereby a higher score signifies increased marker expression. On multivariate analysis, increasing hypoxia score was an independent prognostic factor for cancer-specific survival (p = 0.015) and was borderline significant for overall survival (p = 0.057) when adjusted for other independent predictors of outcomes (hemoglobin and age). Conclusions: We identified a panel of hypoxia-related tissue markers that correlates with treatment outcomes in HNSCC. Validation of these markers will be needed to determine their utility in identifying patients for hypoxia-targeted therapy. (c) 2007 Elsevier Inc.
引用
收藏
页码:167 / 175
页数:9
相关论文
共 50 条
  • [31] Clinical relevance of tumour markers in head and neck squamous cell carcinomas
    Stieber, P
    Wollenberg, B
    Schmitt, UM
    vonJan, N
    Hofmann, K
    FatehMoghadam, A
    TUMORDIAGNOSTIK & THERAPIE, 1996, 17 (04) : 116 - 121
  • [32] CYTOKINE EXPRESSION BY HEAD AND NECK SQUAMOUS-CELL CARCINOMAS
    MANN, EA
    SPIRO, JD
    CHEN, LL
    KREUTZER, DL
    AMERICAN JOURNAL OF SURGERY, 1992, 164 (06): : 567 - 573
  • [33] MicroRNA expression levels in head and neck squamous cell carcinomas
    Chang, S.
    Califano, J.
    ORAL ONCOLOGY, 2007, : 72 - 73
  • [34] Topoisomerase IIα expression in squamous cell carcinomas of the head and neck
    Stathopoulos, GP
    Kapranos, N
    Manolopoulos, L
    Papadimitriou, C
    Adamopoulos, G
    ANTICANCER RESEARCH, 2000, 20 (1A) : 177 - 182
  • [35] A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications
    Chi, Li-Hsing
    Wu, Alexander T. H.
    Hsiao, Michael
    Li, Yu-Chuan
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):
  • [36] ANALYSIS OF PROGNOSTIC FACTORS IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK
    DREYFUSS, AI
    CLARK, JR
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1991, 5 (04) : 701 - 712
  • [37] Prognostic significance of AgNORs in head and neck carcinomas
    Rueschoff, J
    Hermann, J
    Dammer, R
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 1996, 40 (04): : 349 - 349
  • [38] Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck
    Kandiloros, D.
    Eleftheriadou, A.
    Chalastras, T.
    Kyriou, L.
    Yiotakis, I.
    Ferekidis, E.
    MEDICAL ONCOLOGY, 2006, 23 (04) : 463 - 470
  • [39] Squamous cell carcinomas of the head and neck
    Sanderson, RJ
    Ironside, JAD
    BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7368): : 822 - 827
  • [40] Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck
    D. Kandiloros
    A. Eleftheriadou
    T. Chalastras
    L. Kyriou
    I. Yiotakis
    E. Ferekidis
    Medical Oncology, 2006, 23 : 463 - 470